|
2024
|
P/S
|
Pharmaceutical preparations for human use for the prevention and treatment of viral diseases, aut... |
|
|
P/S
|
Pharmaceutical preparations for human use for the prevention
and treatment of viral diseases, au... |
|
|
P/S
|
Biochemical products used in industry and science, namely multivalent proteins, including antibod... |
|
|
P/S
|
Biochemical products used in industry and science, namely
multivalent proteins, including antibo... |
|
|
Invention
|
Bispecific igg antibodies as t cell engagers.
Bispecific IgG antibodies which bind to CLEC12A an... |
|
|
Invention
|
Novel pd-1 binding domains.
The present disclosure relates to novel PD-1 binding domains that ha... |
|
|
Invention
|
Erbb-2 and erbb-3 binding bispecific antibodies for use in the treatment of cells that have an nr... |
|
|
Invention
|
Multivalent antibody.
The invention relates to a multivalent antibody which comprises: a base an... |
|
|
Invention
|
Methods and means for the production of ig-like molecules.
The invention provides means and meth... |
|
|
Invention
|
Binding molecules that inhibit cancer growth.
The invention provides means and methods for inhib... |
|
|
Invention
|
Antibody that binds erbb-2 and erbb-3.
The invention relates among other to antibodies comprisin... |
|
2023
|
Invention
|
Promiscuous cd3 binding molecules.
The present disclosure relates to the field of antibodies. In... |
|
|
Invention
|
Treatment of cancer with a combination of an antibody that binds egfr and cytotoxic drugs. The pr... |
|
|
Invention
|
Promiscuous cd3 binding molecules. The present disclosure relates to the field of antibodies. In ... |
|
|
Invention
|
Method for generating bispecific proteins. Provided herein is a method for producing a heterodime... |
|
|
Invention
|
Combination treatment of cancers using an antibody that binds at least egfr and an immune checkpo... |
|
|
Invention
|
Fap binding domains and bispecific binding moieties that bind fap and tgf-ßrii.
The present disc... |
|
|
Invention
|
Fap binding domains and bispecific binding moieties that bind fap and tgf-βrii. The present discl... |
|
|
Invention
|
Clec12axcd3 bispecific antibodies and methods for the treatment of disease.
The disclosure relat... |
|
|
Invention
|
Antibodies that bind egfr and erbb3.
The invention relates in one aspect to bispecific antibodie... |
|
|
Invention
|
Antibody producing non-human animals.
Described are transgenic, non-human animals comprising a n... |
|
|
Invention
|
Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment of cells that have an nrg... |
|
|
Invention
|
Antibodies that bind egfr and cmet.
The invention as disclosed herein relates to bispecific anti... |
|
|
Invention
|
Means and methods for treating castration-resistant prostate cancer. The invention relates to the... |
|
|
Invention
|
Bispecific anti pd1-anti tim3 antibodies.
The disclosure provide means and methods for interferi... |
|
|
Invention
|
Human cd3 binding antibody.
The invention is among others concerned with human CD3 binding antib... |
|
|
Invention
|
Methods and means for the production of ig-like molecules. The invention provides means and metho... |
|
|
Invention
|
Antibodies that modulate a biological activity expressed by a cell.
The invention provides means... |
|
|
Invention
|
Combination therapy including antibodies that bind egfr and cmet. The invention relates to a comb... |
|
|
Invention
|
Treatment with an antibody that binds egfr and cmet.. The invention as disclosed herein relates t... |
|
|
Invention
|
Combination therapy for the treatment of cancer. The invention relates to the field of binding mo... |
|
2022
|
Invention
|
Binding molecules that bind cd137 and pd-l1.
The invention provides means and methods of stimula... |
|
|
Invention
|
Binding domains against cancer-associated muc1.
The present disclosure relates to binding domain... |
|
|
Invention
|
Binding domains against cancer-associated muc1. The present disclosure relates to binding domains... |
|
|
Invention
|
Binding molecules that modulate a biological activity expressed by a cell.
The invention provide... |
|
|
Invention
|
Multispecific binding moieties comprising pd-1 and tgf-brii binding domains. The present disclosu... |
|
|
Invention
|
Antibody that binds erbb-2 and erbb-3. The invention relates among others to antibodies comprisin... |
|
|
Invention
|
Treatment of immune checkpoint inhibitor-treated cancers with high egfr expression using an antib... |
|
|
Invention
|
Generation of binding molecules.
Provided are methods for efficiently and comprehensively screen... |
|
|
Invention
|
Novel multispecific antibodies.
The present disclosure relates to a multispecific antibody compr... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and i... |
|
|
P/S
|
Human pharmaceutical preparations for the prevention and
treatment of viral diseases, auto-immun... |
|
2021
|
Invention
|
Antibody composition.
The present invention relates to a (bio)pharmaceutical composition, partic... |
|
|
Invention
|
Treatment of cancers with an antibody that binds lgr5 and egfr.
The disclosure relates to means ... |
|
|
P/S
|
(Based on 44(e)) (Based on Use in Commerce) Live animals, namely, transgenic mice (Based on 44(e)... |
|
|
Invention
|
Multispecific antibodies for the treatment of cancer.
The invention is relates to multispecific ... |
|
|
Invention
|
Means and methods for treating subjects with erbb3 mutation positive cancer.
The invention relat... |
|
|
Invention
|
Method for detecting expression or clustering of cell surface moieties.
The present disclosure r... |
|
|
Invention
|
Methods and means for the production of ig-like molecules.
The invention relates to heterodimeri... |
|
|
P/S
|
Living animals; transgenic poultry and avian species. Biochemistry services; laboratory analysis ... |
|
|
P/S
|
Living animals; live animals comprised of transgenic poultry and avian species Biochemistry servi... |
|
|
P/S
|
Biochemical products used in industry and science, namely mutivalent proteins, including antibodi... |
|
|
Invention
|
Means and method for modulating immune cell engaging effects.
The invention relates to a composi... |
|
2020
|
P/S
|
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune... |
|
2019
|
P/S
|
Biochemical products used in industry and science, namely, multivalent proteins, including antibo... |
|
|
P/S
|
Biochemical products used in industry and science, namely, mutivalent proteins, including antibod... |
|
|
P/S
|
Biochemical products used in industry and science, namely
mutivalent proteins, including antibod... |
|
2017
|
P/S
|
Biochemical products used in industry and science, including
in particular antibodies, being pro... |
|
|
P/S
|
Living animals, in particular transgenic mice |
|
|
P/S
|
Biochemical products used in the medical and pharmaceutical industry and in science, in particula... |
|
2012
|
P/S
|
Biochemical products used in industry and science, namely, antibodies, being protein mixtures for... |
|
|
P/S
|
Biochemical products used in industry and science, namely
antibodies, being protein mixtures use... |
|
|
P/S
|
Biochemical products used in industry and science, namely, anti-bodies, being protein mixtures fo... |
|
2010
|
P/S
|
Living animals, in particular transgenic mice. Services of biochemists; services of bacteriologic... |
|
|
P/S
|
Biochemical products used in industry and science, among
which, more in particular antibodies, b... |
